Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

9INV

Crystal structure of DAPK1 in complex with isoliquiritigenin

9INV の概要
エントリーDOI10.2210/pdb9inv/pdb
分子名称Death-associated protein kinase 1, 2',4,4'-TRIHYDROXYCHALCONE, SULFATE ION, ... (4 entities in total)
機能のキーワードdapk1, kinase, inhibitor, isoliquiritigenin, transferase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計34148.72
構造登録者
Yokoyama, T. (登録日: 2024-07-08, 公開日: 2024-10-09)
主引用文献Yokoyama, T.,Hisatomi, K.,Oshima, S.,Tanaka, I.,Okada, T.,Toyooka, N.
Discovery and optimization of isoliquiritigenin as a death-associated protein kinase 1 inhibitor.
Eur.J.Med.Chem., 279:116836-116836, 2024
Cited by
PubMed Abstract: Death-associated protein kinase 1 (DAPK1) is a phosphotransferase in the serine/threonine kinase family. Inhibiting DAPK1 is expected to be beneficial in treating Alzheimer's disease and protecting neuronal cells during cerebral ischemia. In this study, we demonstrated that the natural chalcone isoliquiritigenin inhibits DAPK1 in an ATP-competitive manner, and we synthesized halogen derivatives to amplify the inhibitory effect. Among the compounds tested, the chlorine, bromine, and iodine derivatives exhibited high DAPK1 inhibitory activity and binding affinity. Crystal structure analysis revealed that this improvement is attributable to the halogen atoms fitting well into the hydrophobic pocket formed by I77, L93, and I160. In particular, the chlorine derivative showed a significant enthalpic contribution to the interaction with DAPK1, suggesting its potential as a primary compound for new DAPK1 inhibitors.
PubMed: 39243455
DOI: 10.1016/j.ejmech.2024.116836
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.61 Å)
構造検証レポート
Validation report summary of 9inv
検証レポート(詳細版)ダウンロードをダウンロード

227344

件を2024-11-13に公開中

PDB statisticsPDBj update infoContact PDBjnumon